World
AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders
-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...
May 19, 2025 | News
GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...
May 15, 2025 | News
Thermo Fisher Launches High-Speed, NoSpin Plasmid DNA Kit to Eliminate Bottlenecks in Therapeutic Research
Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rap...
May 14, 2025 | News
BD Launches FACSDiscover™ A8 Cell Analyzer to Expand Access to Advanced Spectral and Real-Time Imaging Technologies
New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...
May 14, 2025 | News
QIAGEN Acquires Genoox to Boost AI-Driven Genomic Interpretation for Clinical Labs Globally
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights...
May 13, 2025 | News
Roche and Genentech Invest $700M in First U.S. East Coast Facility to Advance Obesity Drug Manufacturing
Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investm...
May 13, 2025 | News
Colorcon Enters Exclusive Partnership with ASHA Cellulose to Expand Ethyl Cellulose Offerings Across Asia, EMEA
Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the health...
May 09, 2025 | News
Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse
Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...
May 08, 2025 | News
Taiwan’s Formosa Pharmaceuticals Partners with Apotex to Commercialize APP13007 in Mexico for Post-Ocular Surgery Treatment
Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), ...
May 07, 2025 | News
Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time
Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...
May 07, 2025 | News
Beijing Tide Begins Phase II Trial of First-in-Class Non-Opioid CPSP Drug TRD205
Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class ...
May 06, 2025 | News
Turn Therapeutics Achieves Breakthrough in Room-Temperature Vaccine Stability with 100% Live Virus Recovery
Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced that it has achieved a critical milestone in its effort to r...
May 05, 2025 | News
Asimov and Cytiva Unite to Fast-Track Complex Biologics Production
Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...
April 30, 2025 | News
Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal
Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...
April 30, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
